The textured implants have been associated with an elevated risk of anaplastic large cell lymphoma (ALCL). Allergan has already stopped selling the Biocell textured implants in Europe and Canada. Breast implants come in both textured and smooth formats, with the former resembling sandpaper, making it less likely to move around inside breast and change position. Textured breast implants are more commonly used in Europe than in the US, with it accounting for only 10 per cent of all breast implants sold in the country. Demand for Allergan’s smooth implants may be impacted and litigation claims may rise due to the recall, Stifel analyst Annabel Samimy said, but added that a direct impact from the recall was negligible for the company, which is being bought by AbbVie Inc for $US63 billion ($AU90 billion). Other textured implants sold in the US are made by Sientra Inc and Johnson & Johnson’s Mentor […]
Click here to view original web page at www.brisbanetimes.com.au